Cytrellis, a medical technology company developing a new, proprietary class of micro-coring aesthetic devices for the reduction of sagging skin associated with aging,* was named first runner-up for International Master Course on Aging Science Innovation of the Year and awarded IMCAS Promising Innovation 2020 at the IMCAS Global Market Summit in Paris, France.
| WOBURN, Mass., March 3, 2020 /PRNewswire/ -- Cytrellis, a medical technology company developing a new, proprietary class of micro-coring aesthetic devices for the reduction of sagging skin associated with aging,* was named first runner-up for International Master Course on Aging Science Innovation of the Year and awarded IMCAS Promising Innovation 2020 at the IMCAS Global Market Summit in Paris, France. Fourteen early phase and growth stage start-ups showcased their unique solutions in the fields of dermatology, plastic surgery and aesthetic science. “We are pleased to accept this distinguished award. It’s a tribute to the team’s hard work, fruition of our efforts and most importantly, validation of our potential to deliver unprecedented technology to improve age related changes in the skin,” said Karen Cronholm, President and CEO of Cytrellis. “We are excited to welcome this new category of technology into our armamentarium. We’ve seen notable results in decreasing laxity in our sample population over the age of 55, representing the prime age group seeking this realm of treatment. However, with its local action and low downtime, we think it also has great potential in those younger patients who are starting to see that extra skin but are not quite ready for a facelift,” added Dr. Jill Waibel, Medical Director and Owner of Miami Dermatology and Laser Institute in Miami, Florida.
Cytrellis has developed a micro-coring device which safely and simply removes micro-sized cores of excess skin without energy, scarring or surgery.* Current procedures require the patient to undergo invasive surgery to remove unwanted skin to achieve a significant reduction in sagging skin. Cytrellis’ clinical studies in the mid and lower face have demonstrated a decrease in the area of treated skin, softening of skin folds and reduction of moderate to severe wrinkles. About Cytrellis: Cytrellis, a venture-backed medical technology company, is developing a new, proprietary category of micro-coring devices designed to remove sagging skin associated with aging, without surgery or scarring.* The devices have the potential to provide aesthetic practitioners with an unprecedented ability to improve age related changes in skin and restore youthful beauty. Cytrellis is dedicated to working with leading physicians to develop unique product solutions which emphasize safety, clinical results and improved quality of life. *The Cytrellis device is an investigational product limited by federal law to investigational use. The Cytrellis device has not been cleared for marketing by the U.S. Food and Drug Administration. Contact: Cathleen Alaimo
SOURCE Cytrellis Biosystems Inc. |
View original content to download multimedia:
